Here are Tuesday's biggest analyst calls: Nvidia, Apple, AMD, Micron, Amazon, Eli Lilly, Cloudflare & more
found
Here are Tuesday's biggest calls on Wall Street.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Eli Lilly
since
auto-detected in 104 stories
4 days ago
Bank of America hikes Eli Lilly price target on promising drug pipeline ⊕
Bank of America's new price target has shares of Eli Lilly climbing 22% from here.
5 days ago
What Eli Lilly's move to cut prices on obesity drug Zepbound means for investors
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
found
The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to access.
12 days ago
Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is the best buy from here? ⊕
found
Eli Lilly's stock is soaring while Novo Nordisk is sinking. Why it makes sense to stick with the market winner, despite its rising valuation.
Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Ferrari, Carvana, Eli Lilly, Amazon, Walmart & more
found
Here are Monday's biggest calls on Wall Street.
15 days ago
Eli Lilly hits $1 trillion market value, a first for a health-care company
The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.
19 days ago
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month
found
The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to access.
24 days ago
Here are Wednesday's biggest analyst calls: Nvidia, Apple, Broadcom, Eli Lilly, AT&T, Carvana, Cava, Disney & more
found
Here are Wednesday's biggest calls on Wall Street.
26 days ago
Leerink upgrades Eli Lilly following landmark deal with U.S. government
Leerink Partners sees shares of Eli Lilly adding another 19% from here.